Musashi2 promotes the progression of pancreatic cancer through a novel ISYNA1‐p21/ZEB‐1 pathway

Our previous studies found overexpression of Musashi2 (MSI2) conduced to the progression and chemoresistance of pancreatic cancer (PC) by negative regulation of Numb and wild type p53 (wtp53). Now, we further investigated the novel signalling involved with MSI2 in PC. We identified inositol‐3‐phosph...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Lei, Sheng, WeiWei, Jia, Chao, Shi, Xiaoyang, Cao, Rongxian, Wang, Guosen, Lin, Yiheng, Zhu, Fang, Dong, Qi, Dong, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521282/
https://www.ncbi.nlm.nih.gov/pubmed/32779876
http://dx.doi.org/10.1111/jcmm.15676

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521282/
https://www.ncbi.nlm.nih.gov/pubmed/32779876
http://dx.doi.org/10.1111/jcmm.15676

Ejemplares similares